• ER-Targeting EISA Peptides Induce Selective Cancer Cell Deat

  2026-07-18

  This study presents a novel enzyme-instructed self-assembly (EISA) strategy using endoplasmic reticulum (ER)-targeting peptides to selectively induce apoptosis and necroptosis in cancer cells. By harnessing alkaline phosphatase (ALP) overexpression, the peptide assemblies efficiently accumulate on the ER, offering an advanced approach for modulating cancer cell fate.

• DOTAP (1,2-Dioleoyl-3-trimethylammonium-propane chloride): P

  2026-07-17

  Explore how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) advances nucleic acid delivery and functional genomics. This in-depth analysis uniquely integrates metabolic immune modulation insights and practical transfection strategies, setting it apart from existing content.

• Norovirus Hijacks NINJ1 for Selective Protein Secretion

  2026-07-17

  Song et al. reveal that murine norovirus exploits the host membrane protein NINJ1 to selectively secrete its NS1 protein, using a caspase-3–dependent, unconventional pathway. This mechanistic insight advances understanding of regulated cell death, viral immune evasion, and potential cross-talk with apoptosis research.

• NBC19: Advanced NLRP3 Inflammasome Inhibitor in Inflammation

  2026-07-16

  NBC19 enables precise, nanomolar-level inhibition of the NLRP3 inflammasome, empowering researchers to dissect IL-1β release dynamics in complex inflammatory models. Its rapid, reproducible performance in THP1 cell assays makes it an indispensable tool for troubleshooting inflammasome activation and optimizing cytokine suppression workflows.

• Baicalin Restores Adult Visual Cortex Plasticity in Amblyopi

  2026-07-16

  This study demonstrates that baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity and restores visual acuity in adult mice with amblyopia. The findings offer new mechanistic insight and a potential therapeutic avenue for overcoming critical period closure in adult visual impairment.

• Heparin Sodium: Mechanistic Leverage and Translational Front

  2026-07-15

  This article provides a deep dive into the mechanistic role of Heparin sodium as a glycosaminoglycan anticoagulant, explores its strategic value in translational research, and bridges novel insights into proteoglycan-mediated nanovesicle uptake. Drawing from both established coagulation assays and recent breakthroughs in cross-kingdom nanovesicle delivery, we offer actionable guidance for researchers seeking to advance thrombosis and cell biology studies. APExBIO’s Heparin sodium (SKU A5066) is positioned as a foundational tool for next-generation workflows.

• Elevating Rigor in Epigenetics: Strategic Use of (-)-JQ1 Con

  2026-07-15

  This article delves into the mechanistic and translational imperatives of deploying (-)-JQ1, the gold-standard JQ1 stereoisomer, as an inactive control in BET bromodomain inhibition studies. By integrating recent advances in N-MYC/eIF4G1-driven leukemogenesis and strategic protocol best practices, we offer actionable guidance for translational researchers seeking enhanced specificity and interpretability in cancer biology and epigenetics research.

• Axitinib (AG 013736): Translating VEGF Inhibition to Impact

  2026-07-14

  This thought-leadership article presents a strategic synthesis for translational cancer researchers, bridging mechanistic insights into VEGFR inhibition by Axitinib (AG 013736) with actionable guidance for in vitro and in vivo experimental design. Drawing on published doctoral research and recent workflow advancements, the article explores the biological rationale, comparative landscape, and translational promise of Axitinib, referencing APExBIO’s product intelligence and integrating best practices for robust angiogenesis and tumor response assays.

• Viperin Disrupts Coronavirus Replication via nsp8 Targeting

  2026-07-14

  This study uncovers a distinct mechanism by which viperin inhibits coronavirus replication: direct interaction with non-structural protein 8 (nsp8), disrupting assembly of the viral replication-transcription complex. These findings refine our understanding of interferon-stimulated antiviral pathways and highlight new molecular targets for broad-spectrum RNA virus inhibition.

• Optimizing hiPSC-Derived Platelet Production via Small Molec

  2026-07-13

  This study introduces a systematically optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), incorporating refined embryoid body dosing, serum-free medium, and targeted small molecule modulation. The approach enhances yield, reduces costs, and accelerates timelines, addressing key barriers for scalable platelet manufacture and translational research.

• Tetracycline: Applied Protocols for Ribosomal and ER Stress

  2026-07-13

  Tetracycline’s broad-spectrum activity and ribosomal targeting unlock advanced use-cases—from antibiotic selection to probing endoplasmic reticulum stress in hepatic fibrosis models. Discover stepwise protocols, troubleshooting strategies, and the latest insights for maximizing reproducibility and data quality in microbiological and cell-based assays.

• MLKL Polymerization Triggers Lysosomal Permeabilization in N

  2026-07-12

  This study uncovers how MLKL polymerization directly induces lysosomal membrane permeabilization (LMP), preceding plasma membrane rupture and driving necroptotic cell death. The findings clarify the sequence and mechanisms of organelle disruption in necroptosis, establishing cathepsin B as a critical effector and revealing new intervention points for cell death modulation.

• YAP-TEAD Regulation of Super-Enhancers in Surface Ectoderm F

  2026-07-10

  Wang et al. reveal how the YAP-TEAD transcriptional complex orchestrates super-enhancer networks to guide early surface ectoderm commitment from pluripotent stem cells. Their integration of chromatin profiling and functional perturbation provides mechanistic insight into lineage specification, with implications for regenerative medicine and cell-based research.

• Hypoxia, Immunometabolism, and Tumor Progression: Mechanisti

  2026-07-09

  This review dissects how hypoxia in the tumor microenvironment drives metabolic reprogramming and immune evasion, emphasizing the interplay between glucose metabolism and immunosuppression. The findings provide a mechanistic foundation for metabolism-targeted cancer therapies and highlight experimental considerations for future research.

• AP20187: Precision Chemical Inducer of Dimerization in Gene

  2026-07-09

  AP20187 enables reversible, precision-controlled protein interactions for conditional gene therapy and regulated cell therapy applications. Its robust solubility, validated in vivo performance, and workflow flexibility make it a standout chemical inducer of dimerization for advanced research and translational models.

452 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page